Design, synthesis and SAR of novel sulfonylurea derivatives for the treatment of Diabetes mellitus in rats
作者:Farid M. Sroor、Wahid M. Basyouni、Hanan F. Aly、Sanaa A. Ali、Azza F. Arafa
DOI:10.1007/s00044-021-02829-z
日期:2022.1
Novel series of sulfonylurea analogs were designed, synthesized and fully characterized. The targeted sulfonylurea analogs 3–11, were prepared in a straight forward manner by nucleophilic addition of aryl-sulfonyl hydrazine derivatives 1a–c to alkyl- or aryl-isocyanates 2a–c to give the corresponding sulfonylureas 3–11 in excellent yield. The prepared compounds have been elucidated by IR, elemental
设计、合成并充分表征了新型磺酰脲类似物系列。通过将芳基磺酰肼衍生物1a-c与烷基或芳基异氰酸酯2a-c亲核加成,以极好的收率得到相应的磺酰脲类3-11,以直接的方式制备目标磺酰脲类类似物3-11。所制备的化合物已通过红外光谱、元素分析和核磁共振光谱进行了阐明。进行了制备的化合物相对于抗糖尿病药物(Diamicron MR60)的体内抗糖尿病活性。大多数合成的化合物显示出显着的降低血糖水平的活性。结果表明,类似物4、5和10与 Diamicron (MR) 相比是最活跃的。最有前途的磺酰脲的作用的化合物4,5,和10使用特别选择的生物标记物的肝酶活动(分别AST,ALT,)天冬氨酸和丙氨酸氨基转移酶的作为和碱性磷酸酶(ALP)针对糖尿病状况进行了研究,α-淀粉酶、谷胱甘肽、过氧化脂质、尿素、肌酐、总胆红素 (TB)、ω-谷氨酰转移酶 (γ-GT) 和总脂质 (TL)。还测试和讨论了抗氧化剂、氧化应激生物标志物和组织学检查。SAR